505 results on '"Langdahl, B"'
Search Results
2. Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials
3. Fracture Rates in Children with Cerebral Palsy: A Danish, Nationwide Register-Based Study
4. Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study
5. Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies
6. Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis
7. The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study
8. POS0628 EROSIVE PROGRESSION ASSESSED BY HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY COMPARED TO CONVENTIONAL RADIOGRAPHY: A ONE-YEAR COHORT STUDY IN 310 PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS
9. POS0085 A RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY TO COMPARE SB16 (PROPOSED DENOSUMAB BIOSIMILAR) TO REFERENCE DENOSUMAB IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS: 18-MONTH RESULTS
10. Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study
11. Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis
12. Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study
13. Glucose-Lowering Drugs and Fracture Risk—a Systematic Review
14. A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
15. Type 1 Diabetes and Bone Fragility: Links and Risks
16. Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies
17. Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis
18. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series
19. Osteogenesis imperfecta and the teeth, eyes, and ears—a study of non-skeletal phenotypes in adults
20. Glucagon-like peptide-1 receptor agonists and fracture risk—limitations to current knowledge
21. Skeletal phenotypes in adult patients with osteogenesis imperfecta—correlations with COL1A1/COL1A2 genotype and collagen structure
22. Hypercalcemia after discontinuation of long-term denosumab treatment
23. Protein-based oral rehydration solutions for patients with an ileostomy: A randomised, double-blinded crossover study
24. Temporomandibular disorders and psychosocial status in osteogenesis imperfecta - a cross-sectional study
25. Genetics in Osteoporosis
26. POS1380 AUTOANTIBODIES ARE ASSOCIATED WITH EROSIVE DAMAGE IN THE SECOND AND THIRD METACARPOPHALANGEAL JOINTS ASSESSED BY HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS.
27. POS1151 OPPORTUNISTIC BONE MINERAL DENSITY SCREENING IN PATIENTS UNDERGOING CARDIAC CT SCANS: EFFECT OF USING IMAGES CONTAINING INTRAVENOUS CONTRAST
28. POS0133 HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY FOR THE EVALUATION OF BONE EROSIONS OF METATARSOPHALANGEAL JOINTS IN RHEUMATOID ARTHRITIS: A PILOT STUDY
29. POS0526 HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY AND PREDICTION OF EROSIVE PROGRESSION AS ASSESSED BY THE GOLD STANDARD CONVENTIONAL RADIOGRAPHY IN ESTABLISHED RHEUMATOID ARTHRITIS: A 1-YEAR COHORT STUDY
30. POS0595 THE ASSOCIATION BETWEEN AXIAL AND PERIPHERAL BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS, INCLUDING THE IMPACT OF EROSIVE DISEASE. A HR-pQCT STUDY.
31. Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective
32. Effectiveness and characteristics of multifaceted osteoporosis group education—a systematic review
33. Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease
34. PE.Di-047 - Incidence fracturaire, évolution des douleurs dorsales et de la qualité de vie de patients souffrant d’ostéoporose traités par le tériparatide : Résultats de l’étude Observationnelle Européenne ExFOS (Extended Forsteo® Observational Study)
35. Polymorphisms of Muscle Genes Are Associated with Bone Mass and Incident Osteoporotic Fractures in Caucasians
36. Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis
37. An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis
38. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
39. Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis
40. Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)
41. Polymorphisms in the ALOX12 gene and osteoporosis
42. Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk
43. Genotypes and Haplotypes of the Estrogen Receptor Genes, but Not the Retinoblastoma-interacting Zinc Finger Protein 1 Gene, Are Associated with Osteoporosis
44. Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
45. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial
46. A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk
47. No Association Between Hip Geometry and Four Common Polymorphisms Associated with Fracture: The Danish Osteoporosis Prevention Study
48. Haplotypes of Promoter and Intron 1 Polymorphisms in the COLIA1 Gene Are Associated with Increased Risk of Osteoporosis
49. The Effect of Interleukin-1α Polymorphisms on Bone Mineral Density and the Risk of Vertebral Fractures
50. Challenges in the diagnosis and management of glucocorticoid-induced osteoporosis in younger and older adults.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.